e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Diagnosis of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Creatine phosphokinase elevation is highly predictive of obstructive sleep apnoea syndrome (OSAS) in patients with suspected sleep disordered breathing
S. Lentini, R. Manka, S. Scholtyssek, B. Lüderitz, S. Tasci (Bonn, Germany)
Source:
Annual Congress 2005 - Diagnosis of OSA
Session:
Diagnosis of OSA
Session type:
Thematic Poster Session
Number:
794
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Lentini, R. Manka, S. Scholtyssek, B. Lüderitz, S. Tasci (Bonn, Germany). Creatine phosphokinase elevation is highly predictive of obstructive sleep apnoea syndrome (OSAS) in patients with suspected sleep disordered breathing. Eur Respir J 2005; 26: Suppl. 49, 794
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
The impact of obstructive sleep apnoea hypopnoea syndrome (OSAHS) on serum creatine phosphokinase (CK) levels in children
Source: Annual Congress 2010 - Adenotonsillectomy and paediatric sleep medicine
Year: 2010
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH)
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007
Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001
NT-proBNP in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006
Disturbances of respiratory muscles in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 418s
Year: 2006
The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA)
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
CPAP induces structural changes in the inspiratory muscles of patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 222s
Year: 2002
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept